Ledger.Open graph →
SEC Form D · Amendment · filed September 20, 2018

Hapten Sciences, Inc

Offering
$2.2M
Sold
$1.6M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
MEMPHIS, TN
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (7)

Mark Azzopardi · Triq il-Qatta Swieqi, O1DirectorDaniel Hicklin · Cambridge, MAExec · DirectorDavid Cordo · Cambridge, MADirectorArnold Oronsky · Cambridge, MAExec · DirectorLuke Evnin · Cambridge, MADirectorSakae Asanuma · Cambridge, MAExec · DirectorWesley Capital Management, LLC · New York, NYExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗